**Core Concept**
The patient's symptoms suggest an anticholinergic toxicity, which is a life-threatening condition that occurs when a drug blocks the action of the neurotransmitter acetylcholine in the central and peripheral nervous system. This leads to a range of symptoms, including bradycardia, hypotension, decreased sweating, and salivation.

**Why the Correct Answer is Right**
The likely drug causing these symptoms is an anticholinergic agent, such as an antipsychotic medication (e.g., olanzapine, quetiapine). These medications block the action of acetylcholine at muscarinic receptors in the central nervous system, leading to anticholinergic side effects. The symptoms experienced by the patient are consistent with muscarinic receptor blockade, including bradycardia due to vagal dominance, hypotension, decreased sweating, and decreased salivation.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is not relevant to the scenario described, as it does not relate to anticholinergic toxicity.
**Option B:** This option is incorrect because it does not match the symptoms described, which are characteristic of anticholinergic toxicity.
**Option C:** This option is incorrect because it does not match the symptoms described, which are characteristic of anticholinergic toxicity.

**Clinical Pearl / High-Yield Fact**
Anticholinergic toxicity can be life-threatening and requires immediate medical attention. Patients with psychiatric disorders taking antipsychotic medications should be monitored closely for signs of anticholinergic toxicity, including bradycardia, hypotension, decreased sweating, and salivation.

**Correct Answer:** D.